MAPT and Alzheimer disease: Dysfunction of PI3K/Akt/GSK‐3β signaling pathway will not only lead to insulin deficiency and insulin resistance in DM patients, but also lead to tau hyperphosphorylation in the brain of AD patents.58, 59